Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

LH

Laboratory Corporation o... (LH)

Laboratory Corporation of America Holdings
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:LH
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202414h08Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLaboratory Corporation of America Holdings
08/05/202412h59PR Newswire (US)Labcorp to Webcast Its Annual Meeting of ShareholdersNYSE:LHLaboratory Corporation of America Holdings
07/05/202422h05PR Newswire (US)Invitae Receives Court Approval for Sale to LabcorpNYSE:LHLaboratory Corporation of America Holdings
06/05/202422h40Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNYSE:LHLaboratory Corporation of America Holdings
29/04/202413h00PR Newswire (US)Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BNYSE:LHLaboratory Corporation of America Holdings
25/04/202412h58PR Newswire (US)Labcorp Announces 2024 First Quarter ResultsNYSE:LHLaboratory Corporation of America Holdings
25/04/202403h27PR Newswire (US)Labcorp Announces Winning Bid for Select Assets of InvitaeNYSE:LHLaboratory Corporation of America Holdings
25/04/202403h19PR Newswire (US)Invitae Enters into Agreement with Labcorp for Sale of BusinessNYSE:LHLaboratory Corporation of America Holdings
15/04/202413h00PR Newswire (US)Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood DrawNYSE:LHLaboratory Corporation of America Holdings
11/04/202412h59PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLaboratory Corporation of America Holdings
10/04/202412h49PR Newswire (US)Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection KitNYSE:LHLaboratory Corporation of America Holdings
08/04/202413h00PR Newswire (US)Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development ProgramsNYSE:LHLaboratory Corporation of America Holdings
05/04/202413h00PR Newswire (US)Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical ResearchNYSE:LHLaboratory Corporation of America Holdings
02/04/202413h00PR Newswire (US)Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer ResearchNYSE:LHLaboratory Corporation of America Holdings
01/04/202414h00Business WireXcell Biosciences Strengthens Cell and Gene Therapy Collaboration With LabcorpNYSE:LHLaboratory Corporation of America Holdings
29/03/202414h00PR Newswire (US)The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening LabNYSE:LHLaboratory Corporation of America Holdings
28/03/202413h00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNYSE:LHLaboratory Corporation of America Holdings
27/03/202412h00PR Newswire (US)Labcorp to Announce First Quarter Financial Results on April 25, 2024NYSE:LHLaboratory Corporation of America Holdings
20/03/202412h00PR Newswire (US)Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical TrialsNYSE:LHLaboratory Corporation of America Holdings
16/03/202415h29PR Newswire (US)Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian CancerNYSE:LHLaboratory Corporation of America Holdings
11/03/202413h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLaboratory Corporation of America Holdings
11/03/202413h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLaboratory Corporation of America Holdings
07/03/202419h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLaboratory Corporation of America Holdings
07/03/202416h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLaboratory Corporation of America Holdings
07/03/202413h00PR Newswire (US)Labcorp Launches Weight Loss Management Testing SolutionsNYSE:LHLaboratory Corporation of America Holdings
22/02/202421h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLaboratory Corporation of America Holdings
22/02/202421h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLaboratory Corporation of America Holdings
21/02/202422h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLaboratory Corporation of America Holdings
21/02/202420h38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLaboratory Corporation of America Holdings
21/02/202414h19GlobeNewswire Inc.Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardNYSE:LHLaboratory Corporation of America Holdings
 Showing the most relevant articles for your search:NYSE:LH